Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.124.039185 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Xiaohua Shi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, China-Japan Union Hospital of Jilin University Jilin University Jilin China. Hauptthemen laut MEDLINE: Cystatin C, Glomerular Filtration Rate, Stroke, Creatinine. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
The intraindividual difference between the estimated glomerular filtration rates by cystatin C and creatinine (ie, eGFRdiff) is of clinical importance. This study aimed to investigate the cross‐sectional and longitudinal associations of eGFRdiff with stroke using nationally representative data from the CHARLS (China Health and Retirement Longitudinal Study).
Methods
This study included 11 869 participants (aged ≥45 years) from the CHARLS 2015 for the cross‐sectional analysis. A total of 11 553 participants free of stroke were recruited in 2015 as baseline and followed up to 2020 for the cohort analysis. The eGFRdiff was calculated by subtracting estimated glomerular filtration rate by serum creatinine from estimated glomerular filtration rate by serum cystatin C at baseline. Logistic regression models and Cox proportional hazards models were used to examine the cross‐sectional and longitudinal associations.
Results
The mean age of the participants was 60.3±9.6 years, and 5514 (46.5%) were men. According to the cross‐sectional analysis, a negative eGFRdiff was associated with a greater prevalence of stroke (odds ratio per 1 SD, 0.841 [95% CI, 0.741–0.955]). During a median follow‐up of 5.0 years, 838 individuals (7.3%) experienced incident stroke. A lower baseline eGFRdiff was associated with a greater risk of stroke onset (hazard ratio [HR] per 1 SD, 0.884 [95% CI, 0.817–0.955]). Compared with those in the midrange eGFRdiff group (from −15 to 15 mL/min per 1.73 m 2 ), those in the negative eGFRdiff group (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, China-Japan Union Hospital of Jilin University Jilin University Jilin China.
- Department of Radiology, China-Japan Union Hospital of Jilin University Jilin University Jilin China.
- Department of Endocrinology Changchun University of Chinese Medicine Jilin China.
- Department of Chinese Language and Literature, College of Literature and Communication Qingdao University Shandong China.
- Department of Epidemiology Boston University School of Public Health Boston MA USA.
- Department of Nutrition Harvard T H Chan School of Public Health Boston MA USA.
ORCID-Profile: Chen Sheng, Zhiyuan Wu, Zhongxin Xu, Cancan Cui
Zitieren
APA
Shi, X., Song, J., Chen, F., Zhang, L., Chen, Y., Xu, W., Sheng, C., Wu, Z., Xu, Z., & Cui, C. (2025). Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.039185
Vancouver
Shi X, Song J, Chen F, Zhang L, Chen Y, Xu W, et al. Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.039185
BibTeX
@article{Shi2025,
author = {Shi, Xiaohua and Song, Jiayin and Chen, Fenglin and Zhang, Lingyu and Chen, Yuanmei and Xu, Wanqi and Sheng, Chen and Wu, Zhiyuan and Xu, Zhongxin and Cui, Cancan},
title = {Association of Differences in Cystatin C‐ and Creatinine‐Based Estimated Glomerular Filtration Rate With Prevalence and Incidence of Stroke},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.124.039185}
}
EUVIMED